FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

13997611000001108: Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50078101000001112 Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78197301000001113 Seretide 250 Accuhaler (DE Pharmaceuticals) 60 dose en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Is a Fluticasone 250micrograms/actuation / Salmeterol 50micrograms/actuation dry powder inhaler 60 dose true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Is pack of Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has active ingredient Salmeterol xinafoate false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has active ingredient Salmeterol false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has active ingredient Fluticasone propionate false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has manufactured dose form Conventional release powder for inhalation false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has manufactured dose form Inhalation dosage form false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has AMP Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start